Marinus Pharmaceuticals

marinuspharma.com
142 Temple St
New Haven, CT 06510
Phone: 203-315-0566
Fax: 203-315-0565

Type:

Private

Employees:

20 - 49

Revenue:

< 500k

Industry:

Biotech/Healthcare->BioTech/Drugs

SIC Code:

5122 - Drugs, Proprietaries, and Sundries
Click to Open Details Click to Close Details
Click to Open Details
Christopher Cashman
Title: CEO/President/Chairman
Not Available Executive HQ :203-315-0566 Export
Edward Smith
Title: CFO
Not Available Finance HQ :203-315-0566 Export
Albena Patroneva
Title: Chief Medical Officer
Not Available Medical - Science HQ :203-315-0566 Export
Showing 1 to 3 of 7 entries

Click to Open Details Click to Close Details
Click to Close Details
Click to Close Details

Poll Question

Date Created

Current Result

Votes

Additional Info:

If you don't want to waste too much time looking for company information regarding Marinus Pharmaceuticals, a Biotech/drugs company, check out their Lead411 profile. Our profiles have linkedin data, phone numbers, cfo contacts, and more. It contains helpful contact information regarding top company officials, including that of Marinus Pharmaceuticals's CEO Christopher Cashman, and other Marinus Pharmaceuticals email format addresses within the @marinuspharma.com domain. Marinus Pharmaceuticals is based in New Haven, CT. If you sign up for our free trial you will see our email@marinuspharma.com addresses.

Company Background:

Full company description is available with the free trial.

Ceo Reference:

Christopher Cashman
Have you been looking for contact information, like phone numbers and emails, on Christopher Cashman? Lead411 provides data on him which include twitter, linkedin url, wiki, and biography. There is also Marinus Pharmaceuticals email addresses within the @marinuspharma.com profile so Christopher Cashman's email could be included. Christopher Cashman is part of the Marinus Pharmaceuticals which has its main offices in New Haven, CT. Currently holds the post of CEO/President/Chairman. You can find the company data on Lead411 under the Biotech/drugs industry. Some possible email formats for Christopher Cashman are CCashman@marinuspharma.com, Christopher.Cashman@marinuspharma.com, Christopher@marinuspharma.com, and Christopher_Cashman@marinuspharma.com. If you sign up for our free trial you will see our email@marinuspharma.com addresses.

Similar Companies:

Protedyne Corporation
If you don't want to waste too much time looking for company information regarding Protedyne Corporation, a Biotech/drugs company, check out their Lead411 profile. Our profiles have linkedin data, phone numbers, cfo contacts, and more. It contains helpful contact information regarding top company officials, including that of Protedyne Corporation's CEO Fran Tuttle, and other Protedyne Corporation email format addresses within the @protedyne.com domain. Protedyne Corporation is based in Windsor, CT. If you sign up for our free trial you will see our email@protedyne.com addresses.
Achillion Pharmaceuticals Inc
Lead411 offers quality contact information on a variety of companies including that of Achillion Pharmaceuticals Inc's CEO Milind Deshpande. The company profile also contains facebook info, linkedin accounts, phone numbers, cfo contacts, and Achillion Pharmaceuticals Inc email addresses with the domain format of @achillion.com. Achillion Pharmaceuticals Inc, is in the Biotech/drugs field. If you sign up for our free trial you will see our email@achillion.com addresses.
Protein Sciences Corp
Protein Sciences Corp, is a company that works within the Biotech/drugs. This Meriden, CT-based business. Their profile on Lead411 presents significant contact information such as cfo contacts, phone numbers, linkedin data, and Protein Sciences Corp email format addresses with the @proteinsciences.com domain as well as quality contact info regarding Protein Sciences Corp's CEO Manon Cox. They have their head office in Meriden, CT. If you sign up for our free trial you will see our email@proteinsciences.com addresses.
© 2015 Lead411 Corporation. All Rights Reserved.